Skip to main content
Premium Trial:

Request an Annual Quote

OGT Signs up Kreatech as France Distributor

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Amsterdam-based Kreatech Diagnostics will serve as exclusive distributor of Oxford Genome Technology's CytoSure products in France, OGT said today.

OGT's CytoSure aCGH line includes arrays focused on single disorders and genome-wide arrays for syndromes used by cytogeneticists and molecular biologists.

"Kreatech has vast experience and a broad customer base in the genomic arena, and is perfectly positioned to market our CytoSure range in France," OGT CEO Mike Evans said in a statement.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.